Medscape

Gadolinium-Based Contrast Agents and Brain Safety: Signal vs Noise

Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...
The Bakersfield Californian

RSNA25: Pediatric Study for Bayer's Investigational MRI Contrast Agent Gadoquatrane Meets Primary and Secondary Endpoints

Bayer, a global leader in radiology, today revealed results from the QUANTI Pediatric study, adding to the pharmacokinetic, safety and efficacy data of the investigational low-dose MRI ...
EurekAlert!

Coordination clusters as MRI contrast agents

Magnetic resonance imaging (MRI) has become an indispensable diagnostic modality in clinical medicine. Cluster-based magnetic resonance imaging contrast agents (MRICAs) demonstrate significant ...

The CHMP adopted a positive opinion for Vueway® (gadopiclenol) for its use in pediatric patients under 2 years of age

Bracco Imaging S.p.A., a global leader in diagnostic imaging, announces that on 11 December 2025 the Committee for Medicinal ...
Nasdaq

Bayer Seeks FDA Approval for MRI Contrast Agent Gadoquatrane

Bayer BAYRY announced that it has submitted a new drug application (“NDA”) to the FDA seeking approval for its investigational low-dose gadolinium-based contrast agent (“GBCA”), gadoquatrane, for use ...

Bracco Group: The CHMP adopted a positive opinion for Vueway (gadopiclenol) for its use in pediatric patients under 2 years of age

The benefit-risk ratio of Vueway considered positive in children from birthMILAN, Dec. 19, 2025 /PRNewswire/ -- Bracco Imaging S.p.A., a global leader in diagnostic imaging, announces that on ...